5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Revenue growth similar to METSB.HE's 9.08%. Walter Schloss would see if both companies share industry tailwinds.
120.47%
Gross profit growth similar to METSB.HE's 120.47%. Walter Schloss would assume both firms track common industry trends.
26.84%
EBIT growth similar to METSB.HE's 26.84%. Walter Schloss might infer both firms share similar operational efficiencies.
26.84%
Operating income growth similar to METSB.HE's 26.84%. Walter Schloss would assume both share comparable operational structures.
28.03%
Net income growth comparable to METSB.HE's 28.03%. Walter Schloss might see both following similar market or cost trajectories.
25.00%
EPS growth similar to METSB.HE's 25.00%. Walter Schloss would assume both have parallel share structures and profit trends.
25.00%
Similar diluted EPS growth to METSB.HE's 25.00%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.58%
Share count expansion well above METSB.HE's 0.58%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.58%
Diluted share count expanding well above METSB.HE's 0.58%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-71.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-74.46%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.12%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
2.43%
5Y revenue/share CAGR similar to METSB.HE's 2.43%. Walter Schloss might see both companies benefiting from the same mid-term trends.
-15.16%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
497.93%
10Y OCF/share CAGR in line with METSB.HE's 497.93%. Walter Schloss would see both as similarly efficient over the decade.
-23.94%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-15.81%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
143.23%
Similar net income/share CAGR to METSB.HE's 143.23%. Walter Schloss would see parallel tailwinds or expansions for both firms.
650.00%
5Y net income/share CAGR similar to METSB.HE's 650.00%. Walter Schloss might see both on parallel mid-term trajectories.
66.67%
3Y net income/share CAGR similar to METSB.HE's 66.67%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
52.10%
5Y equity/share CAGR is in line with METSB.HE's 52.10%. Walter Schloss would see parallel mid-term profitability and retention policies.
10.56%
3Y equity/share CAGR similar to METSB.HE's 10.56%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
18.92%
AR growth well above METSB.HE's 18.92%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.95%
Inventory growth well above METSB.HE's 3.95%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.61%
Similar asset growth to METSB.HE's 3.61%. Walter Schloss finds parallel expansions or investment rates.
-2.92%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
7.18%
Debt growth far above METSB.HE's 7.18%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-3.68%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.